Replies to post #366548 on Amarin Corp Plc (AMRN)

[couldbebetter]

While watching NFL football Pfizer did a brief commercial. Not selling
an individual product but in effect establishing confidence in the
Pfizer brand. Most people in the US are aware which vaccination they
received, many of whom received the one made by Pfizer. They know the name.

My belief is that Pfizer could make Vascepa into a highly valued CVD
medication if they choose to. Why? Pfizer has established a level
of goodwill and trust rarely seen in the business world. In the end
the credibility of whoever owns (and sells) Vascepa is what will drive
sales. I am confident that Pfizer could pull it off. Can KM? Honestly,
I doubt it. The sooner AMRN is placed in BP hands the greater will be
the benefit for both CVD patients as well for the BP that owns it.

Some posters are angry with KM. Justified or not the goal of shareholders
in this particular case should be to get KM to place AMRN up for sale, as
it should have done long ago. Hopefully, Alex Denner is working towards
that goal.

[shadolane]

I think you have summed it all up pretty well.

AMRN management is taking care of themselves regardless of the pps.

It really doesn't matter to them.

And as a matter of fact the longer this plays out the longer they can take advantage of it all.

What a joke this has been.

IMO